pubmed.ncbi.nlm.nih.gov

Physiology and pharmacology of the cardiac pacemaker ("funny") current - PubMed

Review

Physiology and pharmacology of the cardiac pacemaker ("funny") current

Mirko Baruscotti et al. Pharmacol Ther. 2005 Jul.

Abstract

First described over a quarter of a century ago, the cardiac pacemaker "funny" (I(f)) current has been extensively characterized since, and its role in cardiac pacemaking has been thoroughly demonstrated. A similar current, termed I(h), was later described in different types of neurons, where it has a variety of functions and contributes to the control of cell excitability and plasticity. I(f) is an inward current activated by both voltage hyperpolarization and intracellular cAMP. In the heart, as well as generating spontaneous activity, f-channels mediate autonomic-dependent modulation of heart rate: beta-adrenergic stimulation accelerates, and vagal stimulation slows, cardiac rate by increasing and decreasing, respectively, the intracellular cAMP concentration and, consequently, the f-channel degree of activation. Four isoforms of hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels have been cloned more recently and shown to be the molecular correlates of native f-channels in the heart and h-channels in the brain. Individual HCN isoforms have kinetic and modulatory properties which differ quantitatively. A comparison of their biophysical properties with those of native pacemaker channels provides insight into the molecular basis of the pacemaker current properties and, together with immunolabelling and other detection techniques, gives information on the pattern of HCN isoform distribution in different tissues. Because of their relevance to cardiac pacemaker activity, f-channels are a natural target of drugs aimed at the pharmacological control of heart rate. Several agents developed for their ability to selectively reduce heart rate act by a specific inhibition of f-channel function; these substances have a potential for the treatment of diseases such as angina and heart failure. In the near future, devices based on the delivery of f-channels in situ, or of a cellular source of f-channels (biological pacemakers), will likely be developed for use in therapies for diseases of heart rhythm with the aim of replacing electronic pacemakers.

PubMed Disclaimer

Cited by

Carbon monoxide modulates electrical activity of murine myocardium via cGMP-dependent mechanisms.
Abramochkin DV, Konovalova OP, Kamkin A, Sitdikova GF. Abramochkin DV, et al. J Physiol Biochem. 2015 Mar;71(1):107-19. doi: 10.1007/s13105-015-0387-y. Epub 2015 Feb 11. J Physiol Biochem. 2015. PMID: 25670496
Electrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug's neuroprotective effects.
Chu HY, Gu Q, Jin GZ, Hu GY, Zhen X. Chu HY, et al. PLoS One. 2010 Oct 1;5(10):e13118. doi: 10.1371/journal.pone.0013118. PLoS One. 2010. PMID: 20957037 Free PMC article.
Increased basal synaptic inhibition of hippocampal area CA1 pyramidal neurons by an antiepileptic drug that enhances I(H).
Peng BW, Justice JA, Zhang K, He XH, Sanchez RM. Peng BW, et al. Neuropsychopharmacology. 2010 Jan;35(2):464-72. doi: 10.1038/npp.2009.150. Neuropsychopharmacology. 2010. PMID: 19776733 Free PMC article.
New Therapeutics for Heart Failure: Focusing on cGMP Signaling.
Mangmool S, Duangrat R, Parichatikanond W, Kurose H. Mangmool S, et al. Int J Mol Sci. 2023 Aug 16;24(16):12866. doi: 10.3390/ijms241612866. Int J Mol Sci. 2023. PMID: 37629047 Free PMC article. Review.
What keeps us ticking: a funny current, a calcium clock, or both?
Lakatta EG, DiFrancesco D. Lakatta EG, et al. J Mol Cell Cardiol. 2009 Aug;47(2):157-70. doi: 10.1016/j.yjmcc.2009.03.022. Epub 2009 Apr 8. J Mol Cell Cardiol. 2009. PMID: 19361514 Free PMC article. Review.

Physiology and pharmacology of the cardiac pacemaker ("funny") current - PubMed